The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
A DeutzmannM GanzF SchönenbergerJ VervoortsF KappesElisa Ferrando-MayPublished in: Oncogene (2014)
DNA replication stress is a major source of DNA strand breaks and genomic instability, and a hallmark of precancerous lesions. In these hyperproliferative tissues, activation of the DNA damage response results in apoptosis or senescence preventing or delaying their development to full malignancy. In cells, in which this antitumor barrier is disabled by mutations (for example, in p53), viability and further uncontrolled proliferation depend on factors that help to cope with replication-associated DNA damage. Replication problems preferentially arise in chromatin regions harboring complex DNA structures. DEK is a unique chromatin architectural factor which binds to non-B-form DNA structures, such as cruciform DNA or four-way junctions. It regulates DNA topology and chromatin organization, and is essential for the maintenance of heterochromatin integrity. Since its isolation as part of an oncogenic fusion in a subtype of AML, DEK has been consistently associated with tumor progression and chemoresistance. How DEK promotes cancer, however, is poorly understood. Here we show that DEK facilitates cellular proliferation under conditions of DNA replication stress by promoting replication fork progression. DEK also protects from the transmission of DNA damage to the daughter cell generation. We propose that DEK counteracts replication stress and ensures proliferative advantage by resolving problematic DNA and/or chromatin structures at the replication fork.
Keyphrases
- dna damage
- circulating tumor
- single molecule
- cell free
- dna repair
- gene expression
- oxidative stress
- transcription factor
- dna damage response
- genome wide
- endothelial cells
- high resolution
- nucleic acid
- stress induced
- cell cycle arrest
- mental health
- signaling pathway
- stem cells
- young adults
- acute myeloid leukemia
- mass spectrometry
- circulating tumor cells
- dna methylation
- mesenchymal stem cells
- induced pluripotent stem cells
- pluripotent stem cells
- pi k akt